ArticleNeuro-oncology advances

Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma.

Abiola A Ayanlaja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.